using retatrutide Phase III study demonstrates 30% weight loss Is a new weight-loss drug

A Mendelian randomization study in Frontiers in Endocrinology found that genetically predicted higher insulin resistance was associated with worse cognitive performance, with changes in brain cortical structure mediating part of the effect

This may change the paradigm of how we view overweight and obesity as cardiovascular risk factors and not just cosmetic concerns and will hopefully expand insurance coverage and access for these medications for weight loss, she says

A.YingG

Many BCBS plans require evidence of previous weight loss attempts before authorizing semaglutide, effectively creating gatekeeping barriers that delay treatment initiation

Retatrutide should only be used under the supervision of a qualified healthcare provider with proper monitoring.

This is exactly why we created our meal plans at Clean Eatz Kitchento solve these exact challenges with high-protein, nutrient-dense, portion-controlled meals that work with GLP-1s, not against them